Epidemics Meet a Pandemic: How COVID-19 is Impacting Alcohol and Substance Use

Wednesday, December 9, 2020 | 10:00am PT / 1:00pm ET

Learn how the pandemic is affecting alcohol and substance use and how employers can both support employees who are struggling now and help prevent problematic use from starting in the future.

Register Now


Across the U.S., 13% of people report starting or increasing substance use to cope with the overwhelming stress and emotions related to COVID-19. Substance use was already an epidemic, and with the recent increased use, decreased social support, and closure of inpatient treatment facilities fueled by the pandemic it has made it even harder for those who are struggling.

Join clinicians and substance use experts Smita Das, MD, PhD, MPH and Liz Rojas, PhD, to learn why substance use is increasing during the pandemic, the impact it could have long term, and what employers can do to better support their employees.

In this webinar you'll learn:

  • The epidemiology of substance use disorders before, during, and the long after COVID-19
  • How both mental health and substance use disorders can contribute to one another
  • An inside look at evidence-based approaches to treating substance use disorders
  • How employers can help prevent substance use issues from escalating into significant impairment with effective behavioral health support

This webinar will be recorded. Not able to attend live? Register anyway, and we'll share a copy of the recording.

The Speakers

Smita Das, MD, PhD, MPH

Medical Director, Psychiatry, Lyra Health

Dr. Das is Board Certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine and has 20 years of experience in healthcare quality and addiction research. She studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She has been a leader in psychiatry, is the immediate past president of the Northern California Psychiatric Society and serves on the Addiction Council of the American Psychiatric Association (APA). Prior to her position as Medical Director of Psychiatry at Lyra Health, she was Director of Addiction Treatment Services at the Palo Alto VA. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Assistant Professor.

Liz Rojas, PhD

Clinical Manager for Blended Care Therapy, Lyra Health

Dr. Rojas oversees the clinical quality and training development for the Blended Care Program. She went to graduate school for her doctorate in clinical psychology at the University of South Florida, where she researched assessments for personality disorders. She then completed her internship at the San Diego VA and post-doctoral fellowship at the Palo Alto VA, where she specialized in the treatment of substance use disorders and PTSD. Prior to joining Lyra, she served on the clinical staff for the Substance Abuse Residential Rehabilitation Program at the Palo Alto VA.

Join us for the webinar

By submitting this form, you are agreeing to Lyra Health's Privacy Policy and Terms of Service.